Orka Two vs Otofonix Groove

The Orka Two is a behind-the-ear prescription hearing aid priced at $1,899, earning an A grade with a SoundScore of 4.0/5 in our lab testing. This places it in the top 67% of the 36 prescription hearing aids we've evaluated, ranking #25 in its category. In our testing, the Orka Two shows a mixed performance profile with clear strengths and weaknesses. Music streaming stands out at 3.3/5, measuring 0.66 points above the category average—a solid result for users who prioritize phone audio quality. Own-voice comfort also performs well at 3.2/5, sitting 0.45 points above average, which may contribute to a more natural listening experience. Feedback handling is excellent at 5.0/5, among the best we've measured. However, speech-in-noise performance is a notable limitation. At 1.4/5, it falls 0.56 points below the category average—a low absolute score that may affect understanding in challenging listening environments like restaurants or group conversations. Speech in quiet fares better at 3.7/5, measuring 0.40 points above average. The Orka Two may suit users who prioritize streaming quality, own-voice comfort, and stability over speech-in-noise performance. Those frequently in noisy environments should note that competitors in this price range, such as the Rexton Reach R-Li T80 at Costco (4.58/5), deliver stronger overall scores. Budget-conscious shoppers might also consider lower-priced alternatives like the Sony CRE-C10, which scored 4.19/5 in our testing.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.